Advanced search
Showing result 1 - 5 of 37 swedish dissertations matching the above criteria.
-
1. Acute Symptomatic Seizure : Clinical and Experimental Studies
Abstract : Epilepsy is defined as a condition with recurrent unprovoked seizures. When seizures are believed to be provoked they fall into another category of situation related seizures, i.e. acute symptomatic seizures (ASS). READ MORE
-
2. Seizure and non-seizure outcomes after epilepsy surgery in selected patient groups
Abstract : This thesis addresses some understudied aspects of epilepsy surgery with special emphasis on children and adolescents. The specific aims were to analyse educational and employment outcomes after epilepsy surgery in childhood or adolescence (Paper I), to analyse long-term seizure outcomes after resective epilepsy surgery in patients with IQ ... READ MORE
-
3. Effects of Vagus Nerve Stimulation and Ketogenic Diet on Quality of Life and Changes in EEG and Sleep
Abstract : When anti-epileptic drugs fail, and epilepsy surgery is found unfeasible or ineffective, there remains a group of at least 25% of children with epilepsy in whom seizure control cannot be achieved. Vagus nerve stimulation (VNS) is an adjunctive treatment for medically refractory epilepsy. READ MORE
-
4. Advancing gene therapy for epilepsy. Translational pre-clinical studies with neuropeptide Y and glial cell-line derived neurotrophic factor
Abstract : Epilepsy is a neurological disorder, affecting approximately 1% of the population. The high rate of drug-resistance in epilepsy in general (30%), and temporal lobe epilepsy (TLE) in particular, pose a serious clinical problem. Thus, novel treatments for drug-resistant epilepsy is highly warranted. READ MORE
-
5. Living with epilepsy : young people with uncomplicated epilepsy and adults with newly debuted epilepsy
Abstract : The aim of this thesis was to illuminate experiences of living with uncomplicated epilepsy, i.e. epilepsy without any associated neurological impainnents. The focus was on young people, aged 13- 22 (II, III, IV), and adults, aged 18-65 (I), with newly debuted epilepsy, i. READ MORE